Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in …

K Heinze, TM Nazeran, S Lee, P Krämer… - The Journal of …, 2022 - Wiley Online Library
ARID1A (BAF250a) is a component of the SWI/SNF chromatin modifying complex, plays an
important tumour suppressor role, and is considered prognostic in several malignancies. …

Cell state of origin impacts development of distinct endometriosis-related ovarian carcinoma histotypes

I Beddows, H Fan, K Heinze, BK Johnson, A Leonova… - Cancer Research, 2024 - AACR
Two cancer histotypes diverge from a common cell of origin epigenetically locked in different
cell states, highlighting the importance of considering cell state to better understand the cell …

The prognostic effect of immune cell infiltration depends on molecular subtype in endometrioid ovarian carcinomas

K Heinze, ES Cairns, S Thornton, B Harris, K Milne… - Clinical Cancer …, 2023 - AACR
Purpose: Endometrioid ovarian carcinoma (ENOC) is the second most-common type of ovarian
carcinoma, comprising 10%–20% of cases. Recently, the study of ENOC has benefitted …

Prognostic and immunological significance of ARID1A status in endometriosis-associated ovarian Carcinoma

K Heinze, TM Nazeran, S Lee, P Krämer, ES Cairns… - MedRxiv, 2021 - medrxiv.org
ARID1A (BAF250a) is a component of the SWI/SNF chromatin modifying complex, plays an
important tumor suppressor role, and is considered prognostic in several malignancies. …

Protein nanocontainers from nonviral origin: testing the mechanics of artificial and natural protein cages by AFM

K Heinze, E Sasaki, NP King, D Baker… - The Journal of …, 2016 - ACS Publications
Self-assembling protein nanocontainers are promising candidates for an increasingly wide
scope of purposes. Their applications range from drug delivery vehicles and imaging agents …

CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer …

K Heinze, M Rengsberger, M Gajda, L Jansen… - Clinical …, 2021 - Springer
Background To date, no predictive or prognostic molecular biomarkers except BRCA mutations
are clinically established for epithelial ovarian cancer (EOC) despite being the deadliest …

Functional analyses of RUNX3 and CaMKIINα in ovarian cancer cell lines reveal tumor-suppressive functions for CaMKIINα and dichotomous roles for RUNX3 …

K Heinze, D Kritsch, AS Mosig, M Dürst… - International journal of …, 2018 - mdpi.com
Karolin Heinze and Norman Häfner established all methods and Karolin Heinze conducted
… Mosig and Karolin Heinze performed FACS analyses. Norman Häfner conducted RUNX3-…

RUNX3 Transcript Variants Have Distinct Roles in Ovarian Carcinoma and Differently Influence Platinum Sensitivity and Angiogenesis

K Heinze, M Hölzer, M Ungelenk, M Gerth, J Thomale… - Cancers, 2021 - mdpi.com
Simple Summary Epithelial ovarian cancer treatment is limited by missing predictive markers,
frequent chemotherapy resistance and an incomplete understanding of the biology of …

Integrated stability and activity control of the Drosophila Rbf1 retinoblastoma protein

L Zhang, Y Wei, I Pushel, K Heinze, J Elenbaas… - Journal of Biological …, 2014 - ASBMB
The retinoblastoma (RB) family transcriptional corepressors regulate diverse cellular events
including cell cycle, senescence, and differentiation. The activity and stability of these …

Versuche zur Identifizierung von Serummarkern in Allergiker-Seren mittels Peptid-Phagen-Display

K Heinze - 2012 - publica.fraunhofer.de
Die Zahl der allergischen Krankheiten, insbesondere Atopische Dermatitis, steigt in den
westlichen Industrieländern. Neue Ansätze der Krankheitsprävention gehen von der …